ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2857 • 2013 ACR/ARHP Annual Meeting

    The Role Of FAM173b As a Newly Identified Regulator Of Chronic Pain

    Hanneke Willemen1, Annemiek Kavelaars2, Rafael González Cano1,3, Cobi Heijnen2 and Niels Eijkelkamp4, 1NIDOD, UMC Utrecht, Utrecht, Netherlands, 2MD Anderson Cancer Center, Houston, TX, 3Department of pharmacology, University of Granada, Granada, Spain, 4Laboratory of Neuroimmunology and Developmental Origins of Disease (NIDOD), UMC Utrecht, Utrecht, Netherlands

    Background/Purpose: Chronic pain is a major debilitating problem in many inflammatory diseases including rheumatoid arthritis and osteoarthritis. Pain is an important problem during active disease…
  • Abstract Number: 2816 • 2013 ACR/ARHP Annual Meeting

    Pilot Phase Outcomes From The ACR/Carra Inter-Institutional Mentoring Program In Pediatric Rheumatology

    Peter A. Nigrovic1,2, Eyal Muscal3, Lakshmi N. Moorthy4, Sampath Prahalad5, Marisa S. Klein-Gitelman6, Meredith P. Riebschleger7, B. Anne Eberhard8 and Rayfel Schneider9, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 3TCH Pediatric Rheum Center, Baylor College of Medicine, Houston, TX, 4Pediatric Rheumatology, Robert Wood Johnson Medical School-Rutgers University, New Brunswick, NJ, 5Pediatrics, Emory Children's Center, Atlanta, GA, 6Division of Rheumatology, Children's Memorial Hospital, Chicago, IL, 7Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI, 8Cohen Children's Hospital Medical Center, New Hyde Park, NY, 9Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati, OH, Canada

    Background/Purpose: In pediatric rheumatology, the small size of many academic programs translates into limited mentoring options for early career physicians. To address this “mentorship gap,”…
  • Abstract Number: 2817 • 2013 ACR/ARHP Annual Meeting

    Objective Assessment Of Musculoskeletal Physical Examination Skills During Continuing Education Programs For Primary Care Providers Adds Significant Information Not Obtained Through Self-Assessment

    Andrea M. Barker1, Michael J. Battistone2, J Peter Beck3, Jorie Butler4, Marissa Grotzke5, Timothy A. Huhtala6, Amy C. Cannella7, David I. Daikh8, Meika A Fang9, Antonio A. Lazzari10, Pedro Roldan11, Joan Marie Von Feldt12 and Grant W. Cannon2, 1General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, 2Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 3Salt Lake City VA and University of Utah, Salt Lake City, UT, 4Salt Lake City VA, Salt Lake City, UT, 5Division of Endocrinology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 6Division of General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, 7Divison of Rheumatology, Omaha Veterans Affairs Hospital and University of Nebraska Medical Center, Omaha, NE, 8Rheumatology, University of California, San Francisco, San Francisco, CA, 9Rheumatology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 10Prim Care/Rheumatology, Boston VA Medical Center, Boston, MA, 11Leesburg VA CBOC, Leesburg, FL, 12Rheumatology, Univ of Pennsylvania/Philadelphia VAMC, Philadelphia, PA

    Background/Purpose: Self-assessment is the most frequently used method in the evaluation of continuing medical education (CME) programs. This multi-institutional project was designed to examine convergent validity…
  • Abstract Number: 2819 • 2013 ACR/ARHP Annual Meeting

    Administration Of a Multi-Epitope Citrullinated Peptide Attuneuates adjuvant  Induced Arthritis In Rats Via Induction Of Immune Tolerance

    Howard Amital1, Smadar Gertel2 and Yehuda Shoenfeld3, 1The Zabludowicz Center For Autoimmune Diseases, and Department of Medicine 'B',, Sheba Medical Center,Tel-Hashomer, Tel-Aviv University, Tel-hashomer, Israel, 2The Zabludowicz Center For Autoimmune Diseases, and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel, 3Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Antigen-induced peripheral tolerance is a potentially efficient and specific therapeutic approach to attenuate autoimmunity. Citrullinated peptides are major targets of disease-specific autoantibodies in Rheumatoid…
  • Abstract Number: 2820 • 2013 ACR/ARHP Annual Meeting

    Disease-Regulated Local Interleukin-10 Gene Therapy Diminishes Synovitis and Articular Cartilage Damage In Experimental Arthritis

    Eline A. Vermeij1, Mathijs G.A. Broeren1, Miranda B. Bennink1, Onno J. Arntz2, Inger Gjertsson3, Wim B. van den Berg1 and Fons A.J. van de Loo1, 1Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Department of Rheumatology and Inflammation Research, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic destructive autoimmune disease and in most patients the disease follows an intermittent course with periods of exacerbation and…
  • Abstract Number: 2821 • 2013 ACR/ARHP Annual Meeting

    Evaluation Of Selective Manipulation Of The CD28 Co-Stimulation Pathway In The Rhesus Monkey Model Of Collagen-Induced Arthritis

    Michel P.M. Vierboom1, Elia Breedveld1, Bert 't Hart1, Flora Coulon2 and Bernard Vanhove3, 1Department of Immunobiology, Biomedical Primate Research Centre, Rijswijk, Netherlands, 2UMR-S 1064, Institut National de la Santé et de la Recherche Médicale, Nantes, France, 3Institut de Transplantation - Urologie - Néphrologie, INSERM UMR-S 1064, Nantes, France

    Background/Purpose: T-cells are important in the pathogenesis of rheumatoid arthritis (RA). T-cell activation depends on at least two signals. Next to the first signal that…
  • Abstract Number: 2822 • 2013 ACR/ARHP Annual Meeting

    IKKε Deficiency Prolongs Neutrophil Survival Paradoxically Prolonging Inflammation In The Absence Of a Type I Interferon Response

    Maripat Corr1, Christopher Chung2, Seong-Kyu Kim3, D. L Boyle4 and G. S. Firestein5, 1Medicine, Univ of California-San Diego, La Jolla, CA, 2Medicine, UCSD School of Medicine, La Jolla, CA, 3Catholic University of Daegu School of Medicine, Daegu, South Korea, 4Div of Rheum, UCSD School of Medicine, La Jolla, CA, 5Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose: Deficiency of the IKK-related kinases IKKε synergizes with the anti-inflammatory effects of IFNß in a murine model of arthritis., and this effect is mediated…
  • Abstract Number: 2823 • 2013 ACR/ARHP Annual Meeting

    FLIP Deficiency In Dendritic Cells Promotes Spontaneous Inflammatory and Erosive Arthritis

    Qi Quan Huang1, Harris R. Perlman2, Robert Birkett3, Renee E. Koessler1, Syamal K. Datta4 and Richard M. Pope5, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine/Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, 4Rheumatology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose: FLIP is an anti-apoptotic protein induced by chronic inflammation.  In this study a mouse line with FLIP deleted in CD11c+ dendritic cells (DCs), that…
  • Abstract Number: 2824 • 2013 ACR/ARHP Annual Meeting

    Urinary Microalbumin Is Associated With Arterial Stiffness In Patients With Rheumatoid Arthritis

    Karima Becetti1, Annette M. Oeser2, Joseph F. Solus3, Paolo Raggi4, C. Michael Stein5 and Cecilia P. Chung1, 1Medicine, Vanderbilt University, Nashville, TN, 2Vanderbilt University, Nashville, TN, 3Medicine, Vanderbilt Medical Center, Nashville, TN, 4University of Alberta, Edmonton, AB, Canada, 5School of Medicine, Division of Clinical Pharmacology, Vanderbilt Medical Center, Nashville, TN

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased risk for cardiovascular disease (CVD). Urinary microalbumin is a risk factor for CVD in the general…
  • Abstract Number: 2825 • 2013 ACR/ARHP Annual Meeting

    The Influence Of Early Menopause On Cardiovascular Risk In Women With Rheumatoid Arthritis

    Emily Pfeifer1, Cynthia S. Crowson2, Shreyasee Amin3, Sherine E. Gabriel4 and Eric L. Matteson5, 1Department of Medicine, Mayo Clinic, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Division of Rheumatology, Mayo Clinic, Rochester, MN, 4Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Lifetime exposure to female sex hormones may play a role in the development and severity of rheumatoid arthritis (RA). These same hormones have also…
  • Abstract Number: 2826 • 2013 ACR/ARHP Annual Meeting

    Performance Of Five Current Risk Algorithms In Predicting Cardiovascular Events In Rheumatoid Arthritis Patients

    Elke.E.A. Arts1, Calin Popa1, Alfons A. den Broeder2, Anne G. Semb3, Tracey Toms4, George Kitas4, Piet L.C.M. van Riel1 and Jaap Fransen5, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, United Kingdom, 5Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Cardiovascular risk in rheumatoid arthritis (RA) is increased. The cardiovascular (CV) risk algorithms used in the general population may underestimate the risk of cardiovascular…
  • Abstract Number: 2827 • 2013 ACR/ARHP Annual Meeting

    Effect Of Biologic Agents On Lipids and Cardiovascular Risk In Rheumatoid Arthritis Patients

    Dimitrios A. Pappas1, Ani John2, Jeffrey R. Curtis3, George W. Reed4, Jeffrey D. Greenberg5, Ashwini Shewade2, Daniel H. Solomon6, Joel M. Kremer7 and Tanya Sommers4, 1Columbia University, New York, NY, 2Genentech Inc., South San Francisco, CA, 3Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4CORRONA, Inc., Southborough, MA, 5Departments of Medicine (Rheum Div) and Hospital for Joint Diseases, New York Hospital for Joint Diseases, New York, NY, 6Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, 7Medicine, Albany Medical College and the Center for Rheumatology, Albany, NY

    Background/Purpose: The risk for cardiovascular disease (CVD) is increased in patients (pts) with RA. The interplay between traditional CV risk factors and inflammatory burden may…
  • Abstract Number: 2828 • 2013 ACR/ARHP Annual Meeting

    The Performance Of The Original and An Updated Cardiovascular Risk Algorithm (SCORE)  In Patients With Rheumatoid Arthritis

    Elke.E.A. Arts1, Calin Popa1, Alfons A. den Broeder2, Anne Grete Semb3, Tracey Toms4, George Kitas4, Piet L.C.M. van Riel1 and Jaap Fransen1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Dudley, United Kingdom

    Background/Purpose: Cardiovascular (CV) risk in rheumatoid arthritis (RA) is increased. The CV risk algorithms for the  general population may underestimate the risk of cardiovascular disease…
  • Abstract Number: 2829 • 2013 ACR/ARHP Annual Meeting

    Statin Adherence and Risk Of Mortality In Patients With Rheumatoid Arthritis: A Population-Based Study

    Mary De Vera1,2, Michal Abrahamowicz3 and Diane Lacaille4, 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 4Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada

    Background/Purpose: Poor adherence with statin therapy is associated with increased mortality in the general population, but no corresponding data are available among patients with rheumatoid…
  • Abstract Number: 2830 • 2013 ACR/ARHP Annual Meeting

    First Stage Of a Simon’s Two-Stage Optimal Approach Supports Placental Transfer Of Hydroxychloroquine and a Reduced Recurrence Rate Of The Cardiac Manifestations Of Neonatal Lupus

    Peter M. Izmirly1, Nathalie Costedoat-Chalumeau2, Amit Saxena3, Amanda Zink4, Zoey Smith3, Deborah Friedman5 and Jill P. Buyon1, 1Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Internal Medicine, Hopital Cochin, Paris, France, 3Rheumatology, New York University School of Medicine, New York, NY, 4NYU Hospital for Joint Diseases, New York University School of Medicine, New York, NY, 5Division of Pediatric Cardiology, New York Medical College, Valhalla, NY

    Background/Purpose: A previous case control study suggested that hydroxychloroquine (HCQ) might prevent the development of cardiac Neonatal Lupus (cardiac NL) in anti-SSA/Ro antibody (ab) exposed…
  • « Previous Page
  • 1
  • …
  • 2061
  • 2062
  • 2063
  • 2064
  • 2065
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology